表紙：コンジュゲーション・ラベリングサービスの世界市場、タンパク質・ペプチドラベリング、低分子・抗体コンジュゲーション：分子タイプ別の分布、主要地域、業界動向と予測（2023年～2035年）

市場調査レポート

商品コード

1319258

コンジュゲーション・ラベリングサービスの世界市場、タンパク質・ペプチドラベリング、低分子・抗体コンジュゲーション：分子タイプ別の分布、主要地域、業界動向と予測（2023年～2035年）

Conjugation & Labeling Services Market: Focus on Protein & Peptide Labeling, Small Molecule & Antibody Conjugation-Distribution by Type of Molecule, Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035

出版日: 2023年04月04日 | 発行: Roots Analysis

| ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,799 754,114円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,099,822円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,665,526円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,828,362円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のコンジュゲーション・ラベリングサービスの市場規模は、予測期間（2023年～2035年）にCAGRで最大10%の成長が予測されています。

サービスプロバイダーへのコンジュゲーション・ラベリング業務のアウトソーシングに対するニーズ

現在、多くの医薬品開発企業や研究機関は、バイオコンジュゲーション化学に関する技術の専門知識を欠いており、また、コンジュゲーションプロセスの実施に不可欠な先進のバイオコンジュゲーション技術も社内で扱えるものは限られています。サービスプロバイダーの関連する経験や専門知識を活用するために、いくつかの組織は抗体コンジュゲーションサービスやタンパク質ラベリング業務を外注することを好みます。サービスプロバイダーは、さまざまな生体分子の化学修飾に必要な幅広い試薬システムやコンジュゲートとともに、確立された手法を備えている傾向があります。これらの要因が相まって、タンパク質ラベリング、抗体ラベリング、抗体コンジュゲーション業務のCROへのアウトソーシングが増加し、市場成長の要因となっています。

コンジュゲーション・ラベリングサービス市場の現状

現在の市場情勢は、抗体コンジュゲーションサービスを提供する企業が170社以上、タンパク質ラベリングサービスを提供する企業が120社以上存在し、世界中に広がっています。全体として、市場は非常に断片化されており、タンパク質、抗体、ペプチド、低分子など、さまざまな種類の生体分子に対してバイオコンジュゲーションサービスを提供するために必要な専門知識を有する超大手、大手、中堅、中小企業が存在しています。特筆すべきは、サービスプロバイダーの78％がハプテンとの抗体コンジュゲーションを提供していることです。特筆すべき例（当レポートでも取り上げています）としては、AAT Bioquest、Abzena、Fina Biosolutions、Life Tein、ProSci、Synaptic Systems、ViroGenなどがあります。

セグメント分析 - 抗体コンジュゲーションサービスがもっとも求められている

研究目的のカスタム抗体コンジュゲーションは、この市場でもっとも求められているサービスです。各社が提供する抗体コンジュゲーションサービスには、HRPコンジュゲーション、ビオチンコンジュゲーション、蛍光ラベリングサービスなどがあります。抗体ラベリングは抗体コンジュゲーションとも呼ばれ、タグを抗体に結合させます。当レポートでは、研究/診断用途に関連する抗体コンジュゲーションサービスをすべて取り上げました。

セグメント分析 - 蛍光タグは生体分子ラベリングに適したツール

蛍光タグはプロテオミクスの分野で、タンパク質の位置や量を検出するために広く採用されています。これらはまた、タンパク質複合体形成中のコンフォメーション変化の同定や生物学的プロセスの追跡にもつながります。また、蛍光プローブに抗体やペプチドをタグ付けして研究目的に利用する企業もあります。

地域分析 - 北米が最大のシェアを占める

ここ数年、タンパク質ラベリング、ペプチドラベリング、低分子コンジュゲーション、抗体コンジュゲーションサービスを提供する企業が着実に増加しています。このうち、バイオコンジュゲーションサービスプロバイダーの大半は北米を拠点としています。

動向の分析 - 市場の需要に合わせて進化するサービスプロバイダー

さまざまなステークホルダーが、その他の工業/非工業企業との提携を結ぶために統合的な努力を行っています。2018年以降、70を超える戦略的提携が結ばれていることは注目に値します。これは、サービスプロバイダーがコンジュゲーション関連の能力を積極的にアップグレードし、バイオコンジュゲートの現在と予想される需要に対応していることを示しています。この分野は絶えず進化しており、ステークホルダーはバイオコンジュゲーションや生体分子のラベリングに関連するイベント（ウェビナー/会議/セミナー/ミーティング/シンポジウム/サミット）に積極的に参加しています。これらのイベントは、企業が自社のアイデアや革新的なバイオコンジュゲーションの方法論/技術を発表し、バイオコンジュゲートのさまざまな応用についてより多くの聴衆と議論するために必要なプラットフォームを提供する可能性が高いです。生体分子を調整する革新的なアプローチと最先端技術への傾倒を考慮すると、市場は予測期間の2023年～2035年に急速なペースで発展する可能性があります。

当レポートでは、世界のコンジュゲーション・ラベリングサービス市場について調査分析し、現在の市場情勢、市場規模、現在と将来の機会などの情報を提供しています。

章の概要
主な前提条件と予測手法
世界のコンジュゲーション・ラベリングサービス市場（2023年～2035年）
コンジュゲーション・ラベリングサービス市場：分子タイプ別の分析
コンジュゲーション・ラベリングサービス市場：分子結合体/ラベリングタイプ別の分析
コンジュゲーション・ラベリングサービス市場：主要地域別の分析

第11章結論

第12章経営陣の考察

第13章付録1：データの表

第14章付録2：企業と組織のリスト

図表

LIST OF TABLES

Table 4.1 Conjugation and Labeling Service Providers: List of Companies
Table 4.2 Conjugation and Labeling Service Providers: Information on Type of Molecule(s) Conjugated / Labeled
Table 4.3 Conjugation and Labeling Service Providers: Information on Type of Molecular Conjugate(s) / Label(s) Used
Table 4.4 Conjugation and Labeling Service Providers: Information on Type of Enzyme(s) Used
Table 4.5 Conjugation and Labeling Service Providers: Information on Type of Hapten(s) Used
Table 4.6 Conjugation and Labeling Service Providers: Information on Conjugation Service(s) Offered
Table 6.1 Conjugation and Labeling Service Providers: List of Companies Profiled
Table 6.2 AltaBioscience: Company Overview
Table 6.3 AltaBioscience: Recent Developments and Future Outlook
Table 6.4 Bachem: Company Overview
Table 6.5 Bachem: Recent Developments and Future Outlook
Table 6.6 Bio-Synthesis: Company Overview
Table 6.7 Cayman Chemical: Company Overview
Table 6.8 Cayman Chemical: Recent Developments and Future Outlook
Table 6.9 CliniSciences: Company Overview
Table 6.10 CliniSciences: Recent Developments and Future Outlook
Table 6.11 Eurogentec: Company Overview
Table 6.12 Eurogentec: Recent Developments and Future Outlook
Table 6.13 GBI: Company Overview
Table 6.14 GBI: Recent Developments and Future Outlook
Table 6.15 Mimotopes: Company Overview
Table 6.16 Mimotopes: Recent Developments and Future Outlook
Table 6.17 Peptide Institute: Company Overview
Table 6.18 Peptide Institute: Recent Developments and Future Outlook
Table 6.19 piCHEM: Company Overview
Table 7.1 Partnerships and Collaborations: Information on Year of Agreement, Type of Partnership and Type of Partner, 2018-2022
Table 7.2 Partnerships and Collaborations: Information on Type of Agreement (Country-wise and Continent-wise), 2018-2022
Table 8.1 List of Global Events related to Conjugation and Labeling of Biomolecules
Table 13.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Table 13.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Table 13.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Table 13.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Table 13.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Table 13.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular

Conjugate(s) / Label(s) Used

Table 13.7 Conjugation and Labeling Service Providers: Distribution by Type of Enzyme(s) Used
Table 13.8 Conjugation and Labeling Service Providers: Distribution by Type of Hapten(s) Used
Table 13.9 Conjugation and Labeling Service Providers: Distribution by Conjugation Service(s) Offered
Table 13.10 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2022
Table 13.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.12 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.13 Partnerships and Collaborations: Distribution by Type of Partner
Table 13.14 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 13.15 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 13.16 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Table 13.17 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Headquarters of Partner
Table 13.18 Most Active Players: Distribution by Number of Partnerships
Table 13.19 Partnerships and Collaborations: Distribution by Region
Table 13.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 13.21 Partnerships and Collaborations: Local and International Agreements
Table 13.22 Global Event Analysis: Cumulative Year-wise Trend, 2018-2022
Table 13.23 Global Event Analysis: Distribution by Event Platform
Table 13.24 Global Event Analysis: Distribution by Type of Event
Table 13.25 Global Event Analysis: Distribution by Year and Type of Event
Table 13.26 Global Event Analysis: Distribution by Location of Event
Table 13.27 Most Active Organizers: Distribution by Number of Events
Table 13.28 Most Active Industry Players: Distribution by Number of Speakers
Table 13.29 Most Active Non-Industry Players: Distribution by Number of Speakers
Table 13.30 Seniority Level of Event Speakers: Distribution by Number of Speakers
Table 13.31 Global Conjugation and Labeling Services Market, 2023-2035 (USD Million)
Table 13.32 Conjugation and Labeling Services Market: Distribution by Type of Molecule, 2023 and 2035
Table 13.33 Conjugation and Labeling Services Market for Proteins, 2023-2035 (USD Million)
Table 13.34 Conjugation and Labeling Services Market for Antibodies, 2023-2035 (USD Million)
Table 13.35 Conjugation and Labeling Services Market for Peptides, 2023-2035 (USD Million)
Table 13.36 Conjugation and Labeling Services Market for Small Molecules, 2023-2035 (USD Million)
Table 13.37 Conjugation and Labeling Services Market for Other Molecules, 2023-2035 (USD Million)
Table 13.38 Conjugation and Labeling Services Market: Distribution by Type of Molecular Conjugate / Label, 2023 and 2035
Table 13.39 Conjugation and Labeling Services Market for Polymers, 2023-2035 (USD Million)
Table 13.40 Conjugation and Labeling Services Market for Haptens, 2023-2035 (USD Million)
Table 13.41 Conjugation and Labeling Services Market for Enzymes, 2023-2035 (USD Million)
Table 13.42 Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035 (USD Million)
Table 13.43 Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035 (USD Million)
Table 13.44 Conjugation and Labeling Services Market for Quantum Dots, 2023-2035 (USD Million)
Table 13.45 Conjugation and Labeling Services Market for Isotopes, 2023-2035 (USD Million)
Table 13.46 Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035 (USD Million)
Table 13.47 Conjugation and Labeling Services Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 13.48 Conjugation and Labeling Services Market in North America, 2023-2035 (USD Million)
Table 13.49 Conjugation and Labeling Services Market in Europe, 2023-2035 (USD Million)
Table 13.50 Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035 (USD Million)
Table 13.51 Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 13.52 Conjugation and Labeling Services Market in Latin America, 2023-2035 (USD Million)

LIST OF FIGURES

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Global Event Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Advantages of Biomolecule Conjugation and Labeling
Figure 3.2 Types of Biomolecular Conjugates and Labels
Figure 4.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Figure 4.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Figure 4.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Figure 4.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Figure 4.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular

Conjugate(s) / Label(s) Used

Figure 4.7 Conjugation and Labeling Service Providers: Distribution by Type of Enzyme(s) Used
Figure 4.8 Conjugation and Labeling Service Providers: Distribution by Type of Hapten(s)Used
Figure 4.9 Conjugation and Labeling Service Providers: Distribution by Conjugation Service(s) Offered
Figure 5.1 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in North America
Figure 5.2 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in Europe
Figure 5.3 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in Asia-Pacific
Figure 7.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2022
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 7.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 7.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 7.7 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Figure 7.8 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Headquarters of Partner
Figure 7.9 Most Active Players: Distribution by Number of Partnerships
Figure 7.10 Partnerships and Collaborations: Distribution by Region
Figure 7.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.12 Partnerships and Collaborations: Local and International Agreements
Figure 8.1 Global Event Analysis: Cumulative Year-wise Trend, 2018-2022
Figure 8.2 Global Event Analysis: Distribution by Event Platform
Figure 8.3 Global Event Analysis: Distribution by Type of Event
Figure 8.4 Global Event Analysis: Distribution by Year and Type of Event
Figure 8.5 Global Event Analysis: Distribution by Location of Event
Figure 8.6 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Figure 8.7 Most Active Organizers: Distribution by Number of Events
Figure 8.8 Most Active Industry Players: Distribution by Number of Speakers
Figure 8.9 Most Active Non-Industry Players: Distribution by Number of Speakers
Figure 8.10 Seniority Level of Event Speakers: Distribution by Number of Speakers
Figure 8.11 Global Event Analysis: Geographical Mapping of Upcoming Events
Figure 9.1 Conjugation and Labeling Services: SWOT Analysis
Figure 9.2 SWOT Factors: Harvey Ball Analysis
Figure 10.1 Global Conjugation and Labeling Services Market, 2023-2035 (USD Million)
Figure 10.2 Conjugation and Labeling Services Market: Distribution by Type of Molecule, 2023 and 2035
Figure 10.3 Conjugation and Labeling Services Market for Proteins, 2023-2035 (USD Million)
Figure 10.4 Conjugation and Labeling Services Market for Antibodies, 2023-2035 (USD Million)
Figure 10.5 Conjugation and Labeling Services Market for Peptides, 2023-2035 (USD Million)
Figure 10.6 Conjugation and Labeling Services Market for Small Molecules, 2023-2035 (USD Million)
Figure 10.7 Conjugation and Labeling Services Market for Other Molecules, 2023-2035 (USD Million)
Figure 10.8 Conjugation and Labeling Services Market: Distribution by Type of Molecular Conjugate / Label, 2023 and 2035
Figure 10.9 Conjugation and Labeling Services Market for Polymers, 2023-2035 (USD Million)
Figure 10.10 Conjugation and Labeling Services Market for Haptens, 2023-2035 (USD Million)
Figure 10.11 Conjugation and Labeling Services Market for Enzymes, 2023-2035 (USD Million)
Figure 10.12 Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035 (USD Million)
Figure 10.13 Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035 (USD Million)
Figure 10.14 Conjugation and Labeling Services Market for Quantum Dots, 2023-2035 (USD Million)
Figure 10.15 Conjugation and Labeling Services Market for Isotopes, 2023-2035 (USD Million)
Figure 10.16 Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035 (USD Million)
Figure 10.17 Conjugation and Labeling Services Market: Distribution by Key Geographical Regions, 2023 and 2035
Figure 10.18 Conjugation and Labeling Services Market in North America, 2023-2035 (USD Million)
Figure 10.19 Conjugation and Labeling Services Market in Europe, 2023-2035 (USD Million)
Figure 10.20 Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 10.21 Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 10.22 Conjugation and Labeling Services Market in Latin America, 2023-2035 (USD Million)
Figure 11.1 Concluding Remarks: Overall Market Landscape
Figure 11.2 Concluding Remarks: Partnerships and Collaborations
Figure 11.3 Concluding Remarks: Global Event Analysis
Figure 11.4 Concluding Remarks: Market Forecast and Opportunity Analysis

Product Code: RA100435

INTRODUCTION

Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody. The synergistic combination of the conjugates and biomolecules confer desired functions, which otherwise are difficult to achieve with individual counterparts. These functionalities offer increased membrane permeability, target specificity, circulation time and enhanced pharmacokinetic properties. It is interesting to highlight that when the modification with conjugates lead to detection (direct / indirect) in bioimaging and immunoassays, bioconjugation is also referred to as biomolecule labeling. Presently, industry stakeholders employ various labeling approaches (fluorescent labeling and isotopic labeling) for protein profiling in order to quantify the compounds, and monitor and visualize the biological processes. Over the last couple of years, the pharmaceutical industry has also witnessed the utility of these complex entities across several application areas, such as development of conjugated drug therapeutics, drug delivery systems, disease diagnosis, invention of diagnostic tools, and high-throughput screening. Presently, a number of players across the globe are actively engaged in providing efficient antibody conjugation services for research purposes. Further, given the rising demand for conjugated biomolecules in the field of research and development, the conjugation and labeling services market is anticipated to witness substantial growth in the foreseen future.

SCOPE OF THE REPORT

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report features:

An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Further, the chapter concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
A company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
An in-depth analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with conjugation and labeling services market, over the forecast period. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market growth.

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the following industry stakeholders:

Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research)
Vishal Rai (Founder, Plabeltech)
Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

KEY MARKET INSIGHTS

The Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Distribution by Type of Molecule Supported (Proteins, Peptides, Small Molecules, Antibodies and Other Molecules), Type of Molecular Conjugate / Label (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes and Other Molecular Conjugates / Labels), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period. Further, it highlights the efforts of several stakeholders engaged in this rapidly emerging domain of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.

Need for Outsourcing Conjugation and Labeling Operations to Service Providers

A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. The service providers tend to be equipped with established methodologies, along with a wide range of reagent systems and conjugates required for the chemical modification of different biomolecules. These factors together will be responsible for market growth through increased outsourcing of protein labeling, antibody labeling and antibody conjugation services to the CROs.

Current Landscape of the Conjugation and Labeling Services Market

The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Overall, the market seems to be well-fragmented, featuring the presence of very large, large, mid-sized and small companies, which have the required expertise to offer bioconjugation services across different types of biomolecules, such as proteins, antibodies, peptides and small molecules. It is worth mentioning that 78% of the service providers offer antibody conjugation with haptens; notable examples (which have also been captured in this report) include AAT Bioquest, Abzena, Fina Biosolutions, Life Tein, ProSci, Synaptic Systems and ViroGen.

Segment Analysis - Antibody Conjugation Services are the most sought

Custom antibody conjugation for research purposes is the most sought service in this market. Some of the antibody conjugation services offered by the companies include conjugation with HRP conjugation, Biotin Conjugation and Fluorescent labeling services. Antibody labeling, which is also known as antibody conjugation, involves conjugating a tag to an antibody. In this report, we have captured all the antibody conjugation services that are relevant to research / diagnostic applications.

Segment Analysis - Fluorescent Tags are preferred tool for Biomolecule Labeling

Fluorescent tags are widely employed in the field of proteomics in order to detect the location of protein and quantity of the protein. These also lead to identification of conformational changes during protein complex formation and tracking the biological processes. Some of the companies also offer tagging of fluorescent probes with antibodies and peptides for research purposes.

Regional Analysis - North America to hold the Largest Share

Over the past few years, there has been a steady increase in the companies offering protein labeling, peptide labeling, small molecule conjugation and antibody conjugation services. Of these, majority of the bioconjugation service providers are based in North America.

Trend Analysis - Service Providers evolving to meet the market demand

Various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. The field is continuously evolving; stakeholders are actively participating in events (webinars / conferences / seminars / meetings / symposiums / summits) related to bioconjugation and labeling of biomolecules. These events are likely to provide the necessary platform for companies to present their ideas, innovative bioconjugation methodologies / techniques and discuss various applications of bioconjugates to a wider audience. Given the inclination towards cutting-edge technologies, along with innovative approaches to tailor the biomolecules, we believe that the conjugation and labeling services market is likely to evolve at a rapid pace, during the forecast period 2023-2035.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED:

Question 1: What is the global market size of antibody conjugation services market?

Answer: The global antibody conjugation services market is anticipated to be worth USD 0.51.9 million by 2030.

Question 2: Which are the leading companies in the antibody conjugation services market?

Answer: Presently, more than 170 companies are engaged in offering antibody conjugation services, worldwide. The top players engaged in this domain (which have also been captured in this report) include Affinity Biologicals, BioLegend, Cell Signalling Technology, FAGUS Antibody Services, Novus Biologicals and ProteoGenix.

Question 3: How many companies offer peptide conjugation services?

Answer: More than 150 service providers possess the capabilities to offer peptide conjugation services.

Question 4: What percentage of service providers are engaged in offering conjugation and labeling services with both fluorescent tags and enzymes?

Answer: Close to 50% of the companies claim to offer conjugation and labeling of biomolecules using both fluorescent tags and enzymes; examples include Affigenix Biosolutions, Designer BioScience, Diatheva, GenPro Biotech and LAMPIRE.

Question 5: How many service providers offer services related to antibody-enzyme bioconjugation?

Answer: Nearly 45% of the service providers claim to have the requisite capabilities to aid in the bioconjugation of antibodies with various enzymes.

Question 7: What are the major factors driving the conjugation and labeling services market?

Answer: The factors driving the conjugation and labeling services market include the surge in demand for novel bioconjugate drugs, advanced drug delivery systems, and enhanced biomedical imaging and biomolecular detection.

Question 8: What are the leading market segments in the conjugation and labeling services market?

Answer: In terms of type of molecular conjugate / label, polymers currently account for the largest share (close to 25%) of the global conjugation and labeling services market. This can be attributed to several advantages offered by these conjugates to the biomolecules, including increased therapeutic potential, better stability, improved physicochemical properties and structural integrity. Further, in terms of type of molecule supported, proteins are likely to capture 45% of the current and future market.

Question 9: Which region captures the highest share in the conjugation and labeling services market?

Answer: Presently, the conjugation and labeling services market is dominated by North America, capturing around 45% of the overall market, followed by Europe (29%).

Question 10: What is the likely growth rate (CAGR) for conjugation and labeling services market?

Answer: The conjugation and labeling services market is projected to grow at a CAGR of ~10% during the forecast period 2023-2035.

CHAPTER OUTLINES

Chapter 1: is a preface providing an introduction to the full report, Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation, 2023-2035.
Chapter 2: provides an executive summary of the key insights captured in our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
Chapter 3: provides a general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Additionally, it concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
Chapter 4: includes detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
Chapter 5: presents a detailed company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
Chapter 6: features detailed profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
Chapter 7: features a detailed analysis of the various partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
Chapter 8: features a detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
Chapter 9: provides information on the affiliated trends, key drivers and challenges, under a reliable SWOT framework. The chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.
Chapter 10: presents a comprehensive market forecast and opportunity analysis, highlighting the future potential of the market till the year 2035. We have segregated the current and upcoming opportunity based on type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).
Chapter 11: summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.
Chapter 12: presents the transcripts of interviews conducted with key stakeholders in this industry. The chapter provides details of our conversations with Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research), Vishal Rai (Founder, Plabeltech), and Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing).
Chapter 13: is an appendix, which contains tabulated data and numbers for all the figures included in the report.
Chapter 14: is an appendix, which contains a list of companies and organizations mentioned in this report.

1. PREFACE

1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Overview of Biomolecule Conjugation and Labeling
3.3. Types of Biomolecular Conjugates and Labels
3.4. Applications of Conjugated and Labeled Biomolecules
3.5. Concluding Remarks

4. CONJUGATION AND LABELING SERVICE PROVIDERS: MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Conjugation and Labeling Service Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Company Size and Location of Headquarters
- 4.2.5. Analysis by Type of Molecule(s) Conjugated / Labeled
- 4.2.6. Analysis by Type of Molecular Conjugate(s) / Label(s) Used
  - 4.2.6.1. Analysis by Type of Enzyme(s) Used
  - 4.2.6.2. Analysis by Type of Hapten(s) Used
- 4.2.7. Analysis by Conjugation Service(s) Offered

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis
- 5.4.1. Conjugation and Labeling Service Providers based in North America
- 5.4.2. Conjugation and Labeling Service Providers based in Europe
- 5.4.3. Conjugation and Labeling Service Providers based in Asia-Pacific

6. COMPANY PROFILES

6.1. Chapter Overview
6.2. AltaBioscience
- 6.2.1. Company Overview
- 6.2.2. Recent Developments and Future Outlook
6.3. Bachem
- 6.3.1. Company Overview
- 6.3.2. Recent Developments and Future Outlook
6.4. Bio-Synthesis
- 6.4.1. Company Overview
- 6.4.2. Recent Developments and Future Outlook
6.5. Cayman Chemical
- 6.5.1. Company Overview
- 6.5.2. Recent Developments and Future Outlook
6.6. CliniSciences
- 6.6.1. Company Overview
- 6.6.2. Recent Developments and Future Outlook
6.7. Eurogentec
- 6.7.1. Company Overview
- 6.7.2. Recent Developments and Future Outlook
6.8. GBI (formerly known as Goodwin Biotechnology)
- 6.8.1. Company Overview
- 6.8.2. Recent Developments and Future Outlook
6.9. Mimotopes
- 6.9.1. Company Overview
- 6.9.2. Recent Developments and Future Outlook
6.10. Peptide Institute
- 6.10.1. Company Overview
- 6.10.2. Recent Developments and Future Outlook
6.11. piCHEM
- 6.11.1. Company Overview
- 6.11.2. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS

7.1. Chapter Overview
7.2. Partnership Models
7.3. Conjugation and Labeling Services: Partnerships and Collaborations
- 7.3.1. Analysis by Year of Partnership
- 7.3.2. Analysis by Type of Partnership
- 7.3.3. Analysis by Year and Type of Partnership
- 7.3.4. Analysis by Type of Partner
- 7.3.5. Analysis by Year of Partnership and Type of Partner
- 7.3.6. Analysis by Type of Partnership and Type of Partner
- 7.3.7. Analysis by Location of Headquarters of Partner
- 7.3.8. Analysis by Type of Partnership and Location of Headquarters of Partner
- 7.3.9. Most Active Players: Analysis by Number of Partnerships
- 7.3.10. Analysis by Geography
  - 7.3.10.1. Intercontinental and Intracontinental Deals
  - 7.3.10.2. Local and International Deals

8. GLOBAL EVENT ANALYSIS

8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Conjugation and Labeling Services: Global Event Analysis
- 8.3.1. Analysis by Year of Event
- 8.3.2. Analysis by Event Platform
- 8.3.3. Analysis by Type of Event
- 8.3.4. Analysis by Year and Type of Event
- 8.3.5. Analysis by Geography
- 8.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Area
- 8.3.7. Most Active Organizers: Analysis by Number of Events
8.4. Global Events: Speaker Analysis
- 8.4.1. Most Active Industry Players: Analysis by Number of Speakers
- 8.4.2. Most Active Non-Industry Players: Analysis by Number of Speakers
- 8.4.3. Analysis by Seniority Level of Event Speakers
8.5. Geographical Mapping of Upcoming Events
8.6. Concluding Remarks

9. SWOT ANALYSIS

9.1. Chapter Overview
9.2. Conjugation and Labeling Services: SWOT Analysis
- 9.2.1. Comparison of SWOT Factors

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview
10.2. Key Assumptions and Forecast Methodology
10.3. Global Conjugation and Labeling Services Market, 2023-2035
10.4. Conjugation and Labeling Services Market: Analysis by Type of Molecule
- 10.4.1. Conjugation and Labeling Services Market for Proteins, 2023-2035
- 10.4.2. Conjugation and Labeling Services Market for Antibodies, 2023-2035
- 10.4.3. Conjugation and Labeling Services Market for Peptides, 2023-2035
- 10.4.4. Conjugation and Labeling Services Market for Small Molecules, 2023-2035
- 10.4.5. Conjugation and Labeling Services Market for Other Molecules, 2023-2035
10.5. Conjugation and Labeling Services Market: Analysis by Type of Molecular Conjugate / Label
- 10.5.1. Conjugation and Labeling Services Market for Polymers, 2023-2035
- 10.5.2. Conjugation and Labeling Services Market for Haptens, 2023-2035
- 10.5.3. Conjugation and Labeling Services Market for Enzymes, 2023-2035
- 10.5.4. Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035
- 10.5.5. Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035
- 10.5.6. Conjugation and Labeling Services Market for Quantum Dots, 2023-2035
- 10.5.7. Conjugation and Labeling Services Market for Isotopes, 2023-2035
- 10.5.8. Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035
10.6. Conjugation and Labeling Services Market: Analysis by Key Geographical Regions
- 10.6.1. Conjugation and Labeling Services Market in North America, 2023-2035
- 10.6.2. Conjugation and Labeling Services Market in Europe, 2023-2035
- 10.6.3. Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035
- 10.6.4. Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035
- 10.6.5. Conjugation and Labeling Services Market in Latin America, 2023-2035

コンジュゲーション・ラベリングサービスの世界市場、タンパク質・ペプチドラベリング、低分子・抗体コンジュゲーション：分子タイプ別の分布、主要地域、業界動向と予測（2023年～2035年）

Conjugation & Labeling Services Market: Focus on Protein & Peptide Labeling, Small Molecule & Antibody Conjugation-Distribution by Type of Molecule, Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035

サービスプロバイダーへのコンジュゲーション・ラベリング業務のアウトソーシングに対するニーズ

コンジュゲーション・ラベリングサービス市場の現状

セグメント分析 - 抗体コンジュゲーションサービスがもっとも求められている

セグメント分析 - 蛍光タグは生体分子ラベリングに適したツール

地域分析 - 北米が最大のシェアを占める

動向の分析 - 市場の需要に合わせて進化するサービスプロバイダー

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 コンジュゲーション・ラベリングサービスプロバイダー：市場情勢

第5章 企業の競争力の分析

第6章 企業プロファイル

第7章 パートナーシップと提携

第8章 世界のイベントの分析

第9章 SWOT分析

第10章 市場予測と機会の分析

第11章 結論

第12章 経営陣の考察

第13章 付録1：データの表

第14章 付録2：企業と組織のリスト